Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 10/2020

01-10-2020 | Computed Tomography | Melanoma

Timing Is Everything: Could Surveillance Imaging Intensity Influence Survival in High-Risk Melanoma?

Authors: Madalyn G. Neuwirth, MD, Edmund K. Bartlett, MD

Published in: Annals of Surgical Oncology | Issue 10/2020

Login to get access

Excerpt

Ibrahim et al.1 present a single-center retrospective study of high-risk melanoma patients after surgical resection and describe the association between surveillance imaging and patient outcomes. The utility of surveillance imaging for melanoma is remarkably understudied and has become increasingly interesting in this era of effective systemic therapy, with some data suggesting that treatment is more effective with a lower disease burden2,3. …
Literature
1.
2.
Pires da Silva I, Lo S, Quek C, et al. Site-specific response patterns, pseudoprogression, and acquired resistance in patients with melanoma treated with ipilimumab combined with anti-PD-1 therapy. Cancer. 2020;126:86–97.
3.
Warner AB, Postow MA. Bigger is not always better: tumor size and prognosis in advanced melanoma. Clin Cancer Res. 2018;24:4915–7.CrossRef
4.
Pace LE, Keating NL. A systematic assessment of benefits and risks to guide breast cancer screening decisions. JAMA. 2014;311:1327–35.CrossRef
5.
Reyes C, DaCosta Byfield S, Linke R, Satram-Hoang S, Teitelbaum AH. The burden of metastatic melanoma: treatment patterns, healthcare use (utilization), and costs. Melanoma Res. 2013;23:159–66.CrossRef
6.
Nijhuis AAG, Dieng M, Khanna N, et al. False-positive results and incidental findings with annual CT or PET/CT surveillance in asymptomatic patients with resected stage III melanoma. Ann Surg Oncol. 2019;26:1860–8.CrossRef
Metadata
Title
Timing Is Everything: Could Surveillance Imaging Intensity Influence Survival in High-Risk Melanoma?
Authors
Madalyn G. Neuwirth, MD
Edmund K. Bartlett, MD
Publication date
01-10-2020
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 10/2020
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-020-08633-0

Other articles of this Issue 10/2020

Annals of Surgical Oncology 10/2020 Go to the issue

Breast Oncology

Factors Predicting Breast Cancer Development in Women During Surveillance After Surgery for Atypical Ductal Hyperplasia of the Breast: Analysis of Clinical, Radiologic, and Histopathologic Features

Translational Research and Biomarkers

Circulating PD-1 mRNA in Peripheral Blood is a Potential Biomarker for Predicting Survival of Breast Cancer Patients

ASO Author Reflections

ASO Author Reflections: What is the Role of Cardiopulmonary Exercise Testing Prior to Oesophagectomy?

Gynecologic Oncology

Should We Abandon Systematic Pelvic and Paraaortic Lymphadenectomy in Low-Grade Serous Ovarian Cancer?

Thoracic Oncology

Near-Infrared Fluorescent Image-Guided Lymphatic Mapping in Esophageal Squamous Cell Carcinoma

ASO Author Reflections

ASO Author Reflections: Long-Term Outcomes of Pulmonary Metastasectomy for Uterine Malignancies: A Multi-institutional Study in the Current Era